News tagged with metastatic cancers
Researchers unravel biochemical factor important in tumor metastasis
A protein called "fascin" appears to play a critical transformation role in TGF beta mediated tumor metastasis, say researchers at Moffitt Cancer Center in Tampa, Fla., who published a study in a recent issue of the Journal of ...
Nov 09, 2011 |
not rated yet |
0
Gene may be good target for tough-to-kill prostate cancer cells
Purdue University scientists believe they have found an effective target for killing late-stage, metastatic prostate cancer cells.
Sep 27, 2011 |
5 / 5 (3) |
0
|
Study finds protein critical to breast cancer cell proliferation, migration
Researchers have found that a protein linked to cell division and migration and tied to increased cell proliferation in ovarian tumors is also present at high levels in breast cancer specimens and cell lines. The protein, ...
Sep 15, 2011 |
not rated yet |
0
Researchers characterize biomechanics of ovarian cells according to phenotype at stages of cancer
Using ovarian surface epithelial cells from mice, researchers from Virginia Tech have released findings from a study that they believe will help in cancer risk assessment, cancer diagnosis, and treatment efficiency ...
Nanotechnology / Bio & Medicine
Jul 05, 2011 |
not rated yet |
0
|
Bristol-Myers pitches its cancer medicine pipeline
(AP) -- Bristol-Myers Squibb Co. executives said Monday they have more than a half-dozen drugs in testing against different cancers and could get important data on them and possibly a couple of approvals this year.
Jun 06, 2011 |
not rated yet |
0
Scientists identify KRAS rearrangements in metastatic prostate cancer
Scientists have uncovered a genetic characteristic of metastatic prostate cancer that defines a rare sub-type of this disease. These findings are published in Cancer Discovery, the newest journal of the American Association for Ca ...
Apr 03, 2011 |
not rated yet |
0
FDA approves new drug for advanced melanoma
The U.S. Food and Drug Administration today approved the use of ipilimumab for the treatment of previously treated metastatic melanoma. It is the first drug approved for metastatic, or advanced, melanoma is more than a decade.
Mar 25, 2011 |
not rated yet |
0
FDA clears first melanoma drug to extend life
(AP) -- The Food and Drug Administration has approved a breakthrough cancer medication from Bristol-Myers Squibb Co. that researchers have heralded as the first drug to prolong the lives of patients with ...
Medicine & Health / Medications
Mar 25, 2011 |
4.3 / 5 (4) |
1
Structure, dynamics of a chemical signal that triggers metastatic cancer revealed
In cancer and other pathological diseases, researchers are discovering that packaging is important: specifically, how DNA – about two meters long when unwound and stretched – coils up and compacts ...
Feb 16, 2011 |
5 / 5 (5) |
0
|
Novel immune system-based gene therapy induces strong responses in metastatic melanoma, sarcoma
Researchers have found that a novel form of personalized therapy that genetically engineers a patient's own anti-tumor immune cells to fight tumors could treat metastatic melanoma and metastatic synovial cell sarcoma, representing ...
Jan 31, 2011 |
5 / 5 (2) |
1
Nanosponges harvest rare cancer marker from blood
Cancer researchers have long hypothesized that tumors release small amounts of proteins that could serve as earlier diagnostic indicators of cancer, but the search for such biomarkers has been hampered by the presence of ...
Nanotechnology / Bio & Medicine
Jan 19, 2011 |
4 / 5 (1) |
0
|
Researchers uncover new risk factors for brain metastases in breast cancer patients
Nearly one-fifth of all metastatic breast cancer patients develop brain metastases and have significantly shorter overall survival than patients who do not have brain involvement. One way to improve the affected patients' ...
Dec 09, 2010 |
not rated yet |
0
Decreased physician reimbursement for hormone therapy may reduce over-treatment of prostate cancer
The use of androgen suppression therapy (AST) in prostate cancer for low-risk cases declined following a decrease in physician reimbursement, according to a study published online TK in The Journal of the National Cancer In ...
Dec 03, 2010 |
5 / 5 (1) |
1
Combination therapy improves survival time for patients with advanced liver cancer
Treatment of inoperable advanced liver cancer with the agent doxorubicin (routinely used to treat this condition) in addition to the agent sorafenib resulted in greater overall survival and progression-free survival, compared ...
Nov 16, 2010 |
not rated yet |
0
Targeted therapy promising for HER2-positive metastatic breast cancer
A new type of breast cancer treatment has shown encouraging activity as a first-line therapy in HER2-positive metastatic disease, researchers reported at the 35th Congress of the European Society for Medical Oncology (ESMO) ...
Oct 08, 2010 |
5 / 5 (1) |
0
